# Granules Pharmaceuticals Inc. – FDA 483, Dec 15, 2023

Source: https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/ac2d6df3-5fe0-4df5-8fc5-fcd3805e2087

> FDA 483 for Granules Pharmaceuticals Inc. on December 15, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Granules Pharmaceuticals Inc.
- Inspection Date: 2023-12-15
- Product Type: drugs
- Office Name: Office of Regulatory Affairs
- Summary: Granules Pharmaceuticals Inc. in Chantilly, VA, was inspected and cited for significant deficiencies in quality control, facility maintenance, equipment qualification, and material segregation. The firm failed to properly manage rejected materials, released drug products without adequate sampling, and operated unqualified equipment, indicating a lack of adherence to good manufacturing practices. These issues pose a risk to the identity, strength, quality, and purity of drug products.

## Related Documents

- [483 - 2026-04-03](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/d8b4fccb-5ec0-4d32-b070-267fbae547e0) — date: April 3, 2026
- [483 - 2025-06-27](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/ff217be2-7175-40cb-a94a-9d59b9094abe) — date: June 27, 2025
- [483 - 2022-07-22](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/8b164ba2-7c87-4681-bcc0-c7ba8f6d66e7) — date: July 22, 2022
- [EIR - 2022-01-28](https://www.keypedia.com/records/eir/granules-pharmaceuticals-inc/67f54236-78b9-4398-93b3-349428010285) — date: January 28, 2022
- [483 - 2022-01-28](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/47bd023e-5880-46d4-9c5a-5d1a6a31f0be) — date: January 28, 2022

## Related Officers

- [Johnny D. Nwankwo](https://www.keypedia.com/people/johnny-d-nwankwo/12d510d9-2ea8-44ae-807f-c8c05f63ce68)
- [ Drug Investigator](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)
- [Yaharn Su](https://www.keypedia.com/people/yaharn-su/75b7f7fd-d853-436e-b538-386a8c6df3cb)
- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)

Company: https://www.keypedia.com/companies/granules-pharmaceuticals-inc/fa93bf3f-822e-47be-9e47-59b1c5446629

Office: https://www.keypedia.com/offices/office-of-regulatory-affairs/ff91c598-cf72-4dbe-a2c8-7519c64cbc64
